Both physiological and pathological angiogenesis are regulated by a delicate balance between angiogenic growth factors and endogenous inhibitors [1] . Tumour growth and metastasis are promoted when this balance is shifted towards angiogenesis. Angiogenesis inhibitors can be used to reverse this trend [2] . Endostatin, a 20-kD fragment of the non-collagenous 1 domain of collagen XVIII-␣1, is a wellcharacterized endogenous angiogenesis inhibitor [1, 3, 4] and is known to inhibit endothelial cell proliferation, and cell migration [5] , and to induce apoptosis [6] . Recently, a mutant form of endostatin with a proline to alanine substitution at position 125 was identified and characterized [7] . P125A-endostatin showed higher binding to endothelial cell surface and exhibited stronger inhibitory effects on both cell proliferation and cell migration [7, 8] . Integrin ␣5␤1 and glypican-1 are the major targets of endostatin [9] . Endostatin binding is known to induce dynamic changes in integrins and associated stress fibres that ultimately lead to inhibition of cell migration [10] . In addition, endostatin has also been shown to antagonize the Wntsignalling pathway [11, 12] 
Confocal and immunofluorescence microscopy
HUVECs, MA148 or human foreskin fibroblasts were transfected with either LAMP1-GFP or LC3-GFP and cultured as previously described [20] . (2.5-20 [20] . ␤-Catenin distribution in cells treated with endostatin was monitored by staining the cells with mouse anti-human ␤-catenin antibody linked to phycoerythrin. Cells were counterstained with DAPI and observed using a Fluoview 1000, Olympus, inverted microscope.
Transfected cells were treated with different concentrations

Western blotting
HUVECs were treated with either P125A-endostatin (20 g/ml) or rapamycin (100 ng/ml) with or without E64d (10 g/ml), a protease inhibitor and pepstatin A (10 g/ml) for 24 hrs in complete medium supplemented with 20 ng/ml of recombinant VEGF-A (R&D Systems). Control and treated cells were then lysed and about 10 g of lysate proteins were used for Western blotting as previously described [20] . [20] . Briefly 
Flow cytometry
Endothelial cells were co-transfected with either scrambled or shRNA specific for Beclin 1 and a DsRed expression construct. Subsequently, cells were treated with P125A-endostatin (20 g/ml). Caspase activation in transfected cells treated with endostatin was assessed by flow cytometry using carboxyfluorescein FLICA apoptosis detection kit (Immunochemistry Technologies, LLC, Bloomington, MN, USA) as previously described
FMK, a carboxyfluorescein (FAM) derivative of benzyloxycarbonyl-valinealanine-aspartic acid-fluoromethyl ketone (zVAD-FMK), irreversibly binds to activated caspases. Caspase activation in apoptotic cells can then be determined by the amount of cellular FAM-VAD-FMK retention.
Statistical analysis
The results are given as the mean standard error. Statistical analysis was performed by using Student's t-test. Differences with P values Ͻ0.05 were considered significant.
with either LC3-GFP, a biomarker for autophagy [21, 22] , or LAMP1-GFP, a marker for lysosomes, autolysosomes, late endosomes and multi-vesicular bodies [23] [24] [25] , and exposed to both native endostatin and P125A-endostatin in the presence of VEGF (20 ng/ml 
Effect of integrin knockdown on autophagic response
Because endostatin binds to the integrins ␣5␤1 [9, 10, 29] 
P125A-endostatin-induced autophagy is Beclin 1-PI-3 kinase dependent
Class III PI-3 kinase-p150-Beclin 1 complex is essential for the vesicle nucleation step in autophagy [30] . To evaluate whether autophagic induction by P125A-endostatin can be inhibited by interfering with the activity of PI-3kinase, 3-MA, a widely used PI3kinase inhibitor [31] , was added to LC3-GFP-transfected HUVEC cultures at a non-toxic concentration. Figure 2C shows 
per cell under similar conditions (Fig. 2D). Endothelial cells transfected with LAMP1-GFP showed similar results (Supplementary S2D and S2E), suggesting that Beclin 1 and PI-3 kinase complex play important roles in endostatin-induced autophagy of endothelial cells.
P125A-endostatin up-regulates Beclin 1 levels
The interaction of Beclin 1 and Bcl-2 in the Beclin 1-Bcl-2 complex has been implicated as a rheostat that regulates the homeostasis of autophagic capacity [15, 32] . In addition, Beclin 1 was also found to interact with a conserved hydrophobic groove in Bcl-xL, a close counterpart of Bcl-2, through a BH3-like domain [16] . (Fig. 3B) . Endostatin treatment reduced the levels of Bcl-2 as has been previously shown [6] (Fig. 3C) Fig. 3E and supplementary S3) . Figure 3F (Fig. 4A) . Concomitant increase in Fig. 5A [33] . The second pathway affected by endostatin involves low-affinity binding to glypican and interruption of Wnt-mediated signalling, resulting in the degradation of ␤-catenin independent of glycogen synthase kinase-3␤ (GSK-3␤) [11, 34] .
Western blot analysis showed gradual increase in Beclin 1 levels that reached a plateau after 16 hrs of P125A-endostatin treatment. In contrast, a reduction in total levels of Bcl-2 was observed over the course of 24-hr P125A-endostatin treatment (Fig. 3A). A similar effect was observed when HUVECs were treated with native endostatin and rapamycin (data not shown). To determine whether endostatin-induced autophagy in endothelial cells involved interactions between Beclin 1 and Bcl-2 family members, endogenous Beclin 1-Bcl-2 or Beclin 1-Bcl-xL complexes were immunoprecipitated with antibodies against Beclin 1 (Fig. 3B). A steady increase in the levels of Bcl-2 and Bcl-xL co-immunoprecipitating with Beclin 1 was observed over 24 hrs. Levels of Beclin 1 complexed with Bcl-2 and Bcl-xL reached a steady state after 16 hrs of treatment
pmols per reaction). Whole-cell lysates from different treatments were evaluated for ␤-catenin, Beclin 1 and ␤-actin levels. (B) HUVECs were co-transfected with LC3-GFP and siRNA specific to ␤-catenin or scrambled control siRNA. The number of autophagic vesicles per siRNA or scrambled siRNA-treated cell was quantified as described previously. Scrambled siRNA-transfected cells were used as a control for the study (n ϭ 3). (C) Expression of ␤-catenin. HUVECs were infected with 500 MOI of either Ad-CMV-␤-catenin (solid dark line) or Ad-CMV-GFP (solid grey line). Infected cells were treated with 20 g/ml of P125A-endostatin (abbr. E) and assessed by FACS analysis for ␤-catenin levels. (D) Expression levels of Beclin 1 in the corresponding treatments were measured by flow cytometry. Fold changes in Beclin 1 were calculated by comparing with Beclin 1 levels in Ad-CMV-␤-catenin-transduced HUVECs treated with P125A-endostatin and that of Ad-CMV-GFP-infected control cells (n ϭ 3).
Beclin 1 levels was observed. ␤-Catenin knockdown led to a small increase in autophagic vesicle formation that was enhanced by P125A-endostatin exposure (Fig. 4B). Similar observations were found in LAMP1-GFP-transfected HUVECs following a 24-hr P125A-endostatin treatment (Supplementary S4A). These results suggest that the Wnt-␤-catenin pathway regulates the induction of autophagy in endothelial cells. To confirm this observation, dominant negative ␤-catenin was expressed in HUVEC. Treatment with endostatin did not affect the turnover rate of the dominant negative ␤-catenin. After 24-hr endostatin treatment, increased expression of dominant negative ␤-catenin was accompanied by increased levels of Beclin 1 and autophagic vesicles (Supplementary S4B and S4C). Collectively, these data demonstrate the involvement of the Wnt-␤-catenin signalling pathway in the induction of autophagy by P125A-endostatin in endothelial cells. To confirm that ␤-catenin expression modulates Beclin 1 levels in HUVECs, cells were infected with a replication-deficient adenovirus that over-expressed ␤-catenin (Ad-CMV-␤-catenin). Ad-CMV-␤-catenin virus infection decreased the levels of Beclin 1 in HUVECs in a concentration-dependent manner compared with the control Ad-CMV-GFP construct (Supplementary S5B). Endostatin treatment significantly reduced the levels of ␤-catenin in the Ad-CMV-GFP-infected cells but did not alter the levels in Ad-CMV-␤-catenin-infected cells (Fig. 4C). Ad-CMV-␤-catenin-infected cells, however, showed reduced levels of Beclin 1 that remained low even in the presence of P125A-endostatin (Fig. 4D) as compared with controls that showed an increase. These results indicate a negative correlation between ␤-catenin and Beclin 1 levels and raise the possibility that ␤-catenin may be one of the regulators of autophagy.
The Wnt-␤-catenin canonical pathway modulates the induction of autophagy in endothelial cells
To determine whether P125A-endostatin-induced changes in ␤-catenin plays an essential role in the induction of autophagy, we attempted to over-ride the effect of endostatin by exogenous activation of the Wnt pathway. As shown in
Because sustained autophagy can lead to cell death, the pathway is also referred to as programmed cell-death type II (PCD II) [30] . Alternatively, inhibiting apoptosis (PCD I) can also activate autophagy and vice versa [35] . [36] . Recent studies using conditional knock-out of VEGF in endothelial cells have elucidated the importance of stress-induced autocrine stimulation of endothelial cells by VEGF [37] . Our studies provide evidence for another survival mechanism, autophagy, that is initiated in angiogenesis inhibitor-treated endothelial cells. In this respect, the effect of endostatin parallels the previous studies with kringle-5 (K5) of human plasminogen [20] . [23] [38] [39] [40] . Although [20, 32] . Total cell lysates were evaluated for Beclin 1 expression. 
Fewer than 10% of endothelial cells undergo apoptosis in response to endostatin (data not shown) suggesting that the majority of the endothelial cells resist death by activating a survival pathway. Endothelial cells possess many redundant survival pathways. For example, endothelial cells treated with chemotherapeutic agents such as carboplatin induce expression of VEGF, a survival growth factor for endothelial cells
Although K5 and endostatin bind to distinct sets of target molecules and affect different signalling systems, both of them increased Beclin 1 levels in endothelial cells. Beclin 1 is involved in vesicle nucleation along with PI-3 kinase and is believed to be an early initiator of autophagy
